General discussion, page-7082

I would like to think it would be a very positive sign. He would know better than most where IHL is with their research & an indication of the results from the research leading up to where we are now.
We believe that IXHL is about to enter a much more liquid market with an audience far more interested/experienced in what we are offering.
Joel has also mentioned they are pursuing a path to a GW pharma outcome. It makes a lot of sense to convert & adds another solid signal to the market we have an excellent chance of success with one or more of our development programs.
IMOO